lg 100268 has been researched along with Carcinogenesis in 1 studies
LG 100268: a retinoid X receptor (RXR) selective compound; structure given in first source
Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, M | 1 |
| Royce, DB | 1 |
| Risingsong, R | 1 |
| Williams, CR | 1 |
| Sporn, MB | 1 |
| Liby, KT | 1 |
1 other study available for lg 100268 and Carcinogenesis
| Article | Year |
|---|---|
The Rexinoids LG100268 and LG101506 Inhibit Inflammation and Suppress Lung Carcinogenesis in A/J Mice.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Carboplatin; Carcinogenesis; Cell Line; Che | 2016 |